Though the "sad reality" is that chemical abortion has become even more prevalent in the U.S. since the overturning of Roe v. Wade in 2022, even in states where abortion is basically outlawed, Pastor Joseph Parker of American Family Radio (AFR) says abortion pill reversal is a "wonderful gift."
A chemical abortion involves taking two different medicines.
Mifepristone is taken first, often at a clinic or at home. It blocks progesterone, a hormone necessary for a baby to grow in the womb. Without progesterone, the uterine lining breaks down, and the pregnancy cannot continue.
At this point, many women regret their choice, and that is where abortion pill reversal comes in. Using the natural hormone progesterone, medical professionals have been able to save many pregnancies, if done in time and before the second part of the regimen, misoprostol, is administered.
This is not new information, but Parker says many people are not aware that it is possible.
"There is a great need for more churches and individuals to take it upon themselves to become better informed and inform their members about this reality," he says.
Parker has gathered information for people to print and share with folks in their community or church, including the number for a 24/7 helpline.
"If you as an individual or your church wants to promote that, that's a wise thing to do," the pro-lifer asserts. "God can use any person or church that really wants to promote the hotline."
"Become a vessel God can use to help save babies," he urges.
The FDA has approved mifepristone for medical pregnancy termination up to 70 days (10 weeks) gestation. In 2023, during the Biden administration, it modified the Risk Evaluation and Mitigation Strategy (REMS) program to allow dispensing through certified pharmacies and telemedicine, removing the prior in-person requirement.
The Health, Education, Labor and Pensions (HELP) Committee wants the FDA to reinstate the removed safety protocols, particularly the in-person dispensing requirement. That change alone has reportedly increased risks of patient harm, coercion and undetected adverse events.
